Company: NCEL
Filing Date: 2025-07-29
Form Type: F-4/A
Source: 0001213900-25-068765
Chunk: 512

Company: NewcelX Ltd.
Filing Date: 2025-07-29
Form: F-4/A
Chunk 512
---
9.99%. Revel Family Ltd. is controlled by Michel Revel, its sole equity owner, who holds voting and dispositive power over the securities. The address of Revel Family Ltd. is 52 HaNasi HaRishon Street, Rehovot, Israel, 7630242. (10)Consists of (i) 58,730 NLS Common Shares held by BIOTECHNOLOGY VALUE FUND II, L.P., (ii) 6,677 NLS Common Shares held by BIOTECHNOLOGY VALUE TRADING FUND OS LP, (iii) 75,983 NLS Common Shares held by BIOTECHNOLOGY VALUE FUND, L.P., (iv) 75,983 NLS Common Shares issuable upon exercise of pre -fundedwarrants exercisable within 60 days of July 9, 2025, held by BVF I GP LLC, (ii) 58,731 NLS Common Shares issuable upon exercise of pre -fundedwarrants exercisable within 60 days of July 9, 2025, held by BVF II GP LLC, (iii) 6,677 NLS Common Shares issuable upon exercise of pre -fundedwarrants exercisable within 60 days of July 9, 2025, held by BVF Partners OS Ltd., (iv) 2,287 NLS Common Shares issuable upon exercise of pre -fundedwarrants exercisable within 60 days of July 9, 2025, held by BVF Partners L.P. The address for Biotechnology Value Fund, or BVF, is 4 4 Montgomery Street, 40 thFloor, San Francisco, CA 94104, Mark N. Lampert is the President of BVF, Inc., the General Partner of BVF Partners L.P., and holds voting and dispositive power over the securities held by BVF. 278

Security Ownership of Certain Beneficial Owners and Management of Kadimastem before the Merger The following tables sets forth information regarding the beneficial ownership of Kadimastem Ordinary Shares as of July9, 2025, by: •each person known by Kadimastem to be the beneficial owner of 5% or more of Kadimastem’s outstanding Ordinary Shares before the consummation of the Merger; •each of its executive officers and directors; •all of its executive officers and directors as a group. Unless otherwise indicated, Kadimast